These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

677 related items for PubMed ID: 20009081

  • 41. Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillator.
    Prystowsky EN.
    Rev Cardiovasc Med; 2001; 2(4):197-205. PubMed ID: 12439369
    [Abstract] [Full Text] [Related]

  • 42. Ventricular tachycardia: tricks and traps.
    Nabar A, Nathani PJ.
    J Assoc Physicians India; 2007 Apr; 55 Suppl():39-42. PubMed ID: 18368866
    [No Abstract] [Full Text] [Related]

  • 43. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
    Mishkin JD, Saxonhouse SJ, Woo GW, Burkart TA, Miles WM, Conti JB, Schofield RS, Sears SF, Aranda JM.
    J Am Coll Cardiol; 2009 Nov 24; 54(22):1993-2000. PubMed ID: 19926003
    [Abstract] [Full Text] [Related]

  • 44. [Ventricular tachycardia].
    Brunckhorst C, Duru F, Scharf C, Schalcher C, Candinas R.
    Praxis (Bern 1994); 2001 Jun 14; 90(24):1073-86. PubMed ID: 11458774
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.
    Al-Khatib SM, Daubert JP, Anstrom KJ, Daoud EG, Gonzalez M, Saba S, Jackson KP, Reece T, Gu J, Pokorney SD, Granger CB, Hess PL, Mark DB, Stevenson WG.
    J Cardiovasc Electrophysiol; 2015 Feb 14; 26(2):151-7. PubMed ID: 25332150
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Sudden cardiac death.
    Antezano ES, Hong M.
    J Intensive Care Med; 2003 Feb 14; 18(6):313-29. PubMed ID: 14984660
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W, Mittleman MA, Rich DQ, Wang PJ, Ruskin JN, Tofler GH, Muller JE, Albert CM, TOVA Investigators.
    Circulation; 2004 Mar 23; 109(11):1386-91. PubMed ID: 14993132
    [Abstract] [Full Text] [Related]

  • 54. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child.
    Kwok SY, Yam N, Lun KS, Chen RH, Au TW, Yung TC.
    Europace; 2018 Sep 01; 20(FI2):f248. PubMed ID: 29401320
    [No Abstract] [Full Text] [Related]

  • 55. [ESC guidelines 2015 for ventricular arrhythmias and prevention of sudden cardiac death. What is new?].
    Fink T, Kuck KH, Metzner A, European Society of Cardiology.
    Herz; 2015 Dec 01; 40(8):1034-42. PubMed ID: 26626552
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. The role of antiarrhythmic drug therapy for the prevention of sudden cardiac death.
    Kamath GS, Mittal S.
    Prog Cardiovasc Dis; 2008 Dec 01; 50(6):439-48. PubMed ID: 18474286
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.